Nuclear Magnetic Resonance Spectrometer Market to Reach $ 1.05 Billion with CAGR of 5.50% - Current Trends and Future Estimations

Market Research Future (MRFR) has published a cooked research report on the “Global Nuclear Magnetic Resonance (NMR) Spectrometer Market” that contains information from 2018 to 2032. The nuclear magnetic resonance (NMR) spectrometer market is estimated to register a CAGR of 5.50% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global nuclear magnetic resonance (NMR) spectrometer market— JEOL Ltd.; Thermo Fisher Scientific Inc.; Bruker; Magritek; Oxford Instruments; Nanalysis Corp.; Anasazi Instruments, Inc.; QOneTec; and Advanced Magnetic Resonance Limited.

Market Highlights

The global nuclear magnetic resonance (NMR) spectrometer market is accounted to register a CAGR of 5.50% during the forecast period and is estimated to reach USD 1.05 Billion by 2032.

The NMR spectrometer market experiences consistent demand from pharmaceutical, academic, and research sectors. Advancements in spectroscopy technology, wider adoption in drug discovery, and structural analysis contribute to its growth as a crucial analytical tool.

Segment Analysis

The global nuclear magnetic resonance (NMR) spectrometer market has been segmented based product, type and end-use.

On the basis of product, the market is segmented into instruments and consumables. The instruments segment dominated the market in 2022. Rising investments in R&D projects across several industries, including pharmaceuticals, biotechnology, chemistry, and materials science, are what is driving the need for better NMR spectrometers.   

Based on type, the global nuclear magnetic resonance (NMR) spectrometer market has been segmented into low-field NMR spectroscopy and high-field NMR spectroscopy. The high-field NMR spectroscopy segment dominated the market in 2022. In comparison to lower field equipment, high-field NMR spectrometers offer higher sensitivity and resolution.

Based on end-use, the global nuclear magnetic resonance (NMR) spectrometer market has been segmented into academic, pharmaceutical & biotech companies, agriculture & food, chemical industry and others. The pharmaceutical & biotech companies category generated the most income in 2022. For the development of new pharmaceuticals, pharmaceutical and biotech businesses significantly rely on NMR spectroscopy.

Regional Analysis

The global nuclear magnetic resonance (NMR) spectrometer market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Nuclear magnetic resonance (NMR) spectrometer market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Nuclear magnetic resonance (NMR) spectrometer market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Nuclear magnetic resonance (NMR) spectrometer market comprises of Middle East, Africa, and Latin America.

The North America nuclear magnetic resonance NMR spectrometer market dominated this market in 2022 (45.80%). North America is a hub for research and innovation, particularly inside the United States. Leading academic institutions and research institutes, including MIT and Stanford, spend heavily in cutting-edge NMR spectrometers to assist research in a range of disciplines, such chemistry, biology, and materials science. Because of the U.S.'s booming pharmaceutical and biotechnology sector, which is exemplified by companies like Pfizer, there is a steady need for NMR technology. These companies progress the pharmaceutical industry by using NMR spectroscopy for structural analysis, quality assurance, and medication development.

Moreover, the second-largest market share for nuclear magnetic resonance NMR spectrometers is held by Europe. Outstanding intellectual and scientific achievement has a long history in Europe. Reputable organizations like the University of Cambridge in the UK employ NMR spectrometers to research a range of academic subjects, from materials science to molecular biology. Companies like Roche in the European pharmaceutical and biotechnology industries employ NMR spectroscopy to characterize biopharmaceuticals and develop novel medicines.

Additionally, the Asia-Pacific Nuclear magnetic resonance NMR spectrometer market is expected to grow at the fastest CAGR from 2023 to 2032. Biocon in India is one of the many biopharmaceutical companies that use NMR spectroscopy to ensure the quality and safety of biologic products. Collaborative ecosystems are what propel NMR research, as seen in South Korea with institutions like the Korea Basic Science Institute (KBSI). Government support, such as that given by Japan's MEXT (Ministry of Education, Culture, Sports, Science and Technology), helps to improve scientific capabilities.

Furthermore, the rest of the world's nuclear magnetic resonance (NMR) spectrometer market is divided into the Middle East, Africa, and Latin America. In Latin America, the NMR spectrometer market witnesses steady growth driven by academic and research sectors' demand. Increasing applications in drug discovery and structural analysis support its role as a vital analytical tool.

Key Findings of the Study

• The global nuclear magnetic resonance (NMR) spectrometer market is expected to reach USD 1.05 Billion by 2032, at a CAGR of 5.50% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market. One of the numerous biopharmaceutical businesses using NMR spectroscopy to guarantee the quality and safety of biologic medications is Biocon in India.


• Based on type, the high-field NMR segment was attributed to holding the largest market in 2022.


• JEOL Ltd.; Thermo Fisher Scientific Inc.; Bruker; Magritek; Oxford Instruments; Nanalysis Corp.; Anasazi Instruments, Inc.; QOneTec; and Advanced Magnetic Resonance Limited.